PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€31.20
Target price
20.06.25
€49.47
Performance (%)
-1.92%
Price
22.08.24
€29.40
Summary
This prediction is currently active. With a performance of -1.92%, the BUY prediction for PTC Therapeutics Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 20.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 0.685% | 0.685% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $53.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€48.82
21.05.25
21.05.25
-16.00%
22.08.24
22.08.24